Informativa e consenso per l'uso dei cookie

Accetto Il nostro sito salva piccoli pezzi di informazioni (cookie) sul dispositivo, al fine di fornire contenuti migliori e per scopi statistici. È possibile disattivare l'utilizzo di cookies modificando le impostazioni del tuo browser. Continuando la navigazione si acconsente all'utilizzo dei cookie.

1330-43-4 - Borate, 0.5M buffer soln., pH 8.5 - J60803 - Alfa Aesar

J60803 Borate, 0.5M buffer soln., pH 8.5

Codice CAS
1330-43-4
Sinonimi

Dimensioni Prezzo ($) Quantità Disponibilità
250ml 48,20
500ml 72,31
Aggiungi al carrello Aggiungi al preventivo generale Visualizza articolo

Borate, 0.5M buffer soln., pH 8.5

MDL
MFCD00163147

Proprietà chimiche

Modulo
Liquid
Solubilità
Soluble in water 26 g/L (20°C).

Applicazioni

Borate buffered saline has been used to determine whether heat-killed, borate-buffered suspensions of Gordonia bronchialis, Rhodococcus coprophilus or Tsukamurella inchonensis can be used to treat canine flea allergy. Borate buffered saline has also been used to investigate the effects of lentivirus mediated siRNA targeting human metastasis suppressor 1 (MTSS1, MIM-B gene) gene on the invasive and metastatic potentials of hepatocellular carcinoma (HCC) MHCC97H cells. Borate buffered saline has been used to determine the effects of packaging solution osmolality and buffering agent on soft contact lens parameters. BBS has many uses because it is isotonic and has a strong bactericidal effect. It can be used to dilute substances and in coating procedures. Additives such as Tween 20 and milk powder can be used to add function as washing buffer or blocking buffer. Finfs uses in Protein-coating on microtiter plates, Blocking solution in blots together with Casein or BSA.

Note

Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Letteratura

Edward Lum et. al. Osmolality and buffering agents in soft contact lens packaging solutions. . Contact Lens and Anterior Eye. 2004, 27 (1), 21-26.

Alicia Marro et. al. Successful immunotherapy of canine flea allergy with injected Actinomycetales preparations. Immunotherapy. 2011, 3 (8), 971-978 .

Rischio GHS e dichiarazioni precauzionali

Dichiarazioni di rischio (UE): H360

May damage fertility or the unborn child.

Dichiarazioni precauzionali: P201-P281-P202-P308+P313-P405-P501a

Obtain special instructions before use. Use personal protective equipment as required. Do not handle until all safety precautions have been read and understood. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Altri riferimenti

Codice tariffe armonizzato
2840.19
TSCA
Yes

Raccomandato

  • A14688

    1,1'-Carbonyldiimidazole, 97%
  • B21316

    1,4-Diaminobutane, 98+%
  • J61855

    Glycine, 0.2M buffer soln., pH 2.5
  • J60068

    Sodium borate, 0.5M buffer soln., pH 8.0
  • H54447

    beta-D-Lactose, contains ≈70% beta and ≈30% alpha

Visualizzati di recente

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio